ENTERO

Entero Healthcare Solutions Limited

Pharmacy and healthcare distribution platform

Consumer Discretionary›Consumer Services›Retailing›Pharmacy Retail

enterohealthcare.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1585.00
Market cap
6,897 Cr
Stock P/E
55.0
P/B
4.08
ROE (FY26)
6.6%
ROCE (FY26)
10.1%
Operating margin (FY26)
3.4%
Debt / equity (FY26)
0.34
OCF / EBITDA (FY26)
36.2%
OCF / EBITDA (3Y)
-3.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Entero (Entero Healthcare Solutions) is a wholesale distributor of pharmaceuticals and medical technology (MedTech) products, supplying retailers across India on behalf of manufacturers.

Company snapshot

2ndBy market cap

Ranked among 2 companies in Pharmacy Retail.

What we see

Concerns
  • ✗Net margin is very thin at 2.2% — little room for error if costs rise.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales993 Cr1,034 Cr1,097 Cr1,301 Cr1,359 Cr1,339 Cr1,404 Cr1,571 Cr1,707 Cr1,910 Cr1,940 Cr
Operating expenses (approx.)964 Cr1,005 Cr1,067 Cr1,258 Cr1,309 Cr1,290 Cr1,354 Cr1,509 Cr1,639 Cr1,824 Cr1,844 Cr
EBITDA29 Cr29 Cr30 Cr42 Cr50 Cr49 Cr50 Cr62 Cr68 Cr86 Cr97 Cr
OPM %2.9%2.8%2.8%3.3%3.7%3.7%3.6%4.0%4.0%4.5%5.0%
Other income2 Cr9 Cr13 Cr11 Cr7 Cr7 Cr6 Cr5 Cr5 Cr4 Cr3 Cr
Interest16 Cr17 Cr10 Cr11 Cr10 Cr10 Cr11 Cr12 Cr14 Cr17 Cr21 Cr
Depreciation6 Cr7 Cr7 Cr7 Cr8 Cr8 Cr9 Cr10 Cr10 Cr15 Cr12 Cr
Profit before tax8 Cr14 Cr27 Cr35 Cr39 Cr37 Cr36 Cr45 Cr40 Cr58 Cr67 Cr
Tax %16.1%-56.2%24.8%25.1%25.3%15.6%16.9%18.0%16.1%22.1%22.5%
Net profit7 Cr21 Cr21 Cr26 Cr29 Cr31 Cr30 Cr37 Cr34 Cr45 Cr52 Cr
EPS (₹)₹1.91₹5.73₹4.62₹5.43₹5.85₹5.91₹6.39₹7.26₹6.35₹6.44₹8.77

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,780 Cr2,522 Cr3,300 Cr3,922 Cr5,096 Cr6,591 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,758 Cr2,498 Cr3,236 Cr3,810 Cr4,924 Cr6,325 CrSign in free for the trailing twelve months
EBITDA22 Cr24 Cr64 Cr112 Cr172 Cr266 CrSign in free for the trailing twelve months
OPM %1.2%1.0%1.9%2.9%3.4%4.0%Sign in free for the trailing twelve months
Other income4 Cr4 Cr6 Cr14 Cr40 Cr19 CrSign in free for the trailing twelve months
Interest20 Cr29 Cr49 Cr66 Cr42 Cr54 CrSign in free for the trailing twelve months
Depreciation16 Cr20 Cr24 Cr25 Cr31 Cr43 CrSign in free for the trailing twelve months
Profit before tax-11 Cr-20 Cr-4 Cr36 Cr139 Cr179 CrSign in free for the trailing twelve months
Tax %-41.7%-48.6%-201.1%-11.9%22.6%18.7%Sign in free for the trailing twelve months
Net profit-15 Cr-29 Cr-11 Cr40 Cr107 Cr146 CrSign in free for the trailing twelve months
EPS (₹)₹-5.29₹-9.22₹-3.10₹10.81₹21.80₹26.44Sign in free for the trailing twelve months
Dividend payout %———0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital0.10 Cr4 Cr4 Cr43 Cr44 Cr44 Cr
Reserves485 Cr557 Cr591 Cr1,595 Cr1,681 Cr1,645 Cr
Borrowings142 Cr285 Cr374 Cr276 Cr299 Cr567 Cr
Other liabilities205 Cr278 Cr338 Cr428 Cr633 Cr1,281 Cr
Total liabilities834 Cr1,126 Cr1,309 Cr2,345 Cr2,703 Cr3,600 Cr
Fixed assets (net)41 Cr46 Cr43 Cr93 Cr132 Cr103 Cr
CWIP—0.59 Cr——0 Cr0 Cr
Investments———0 Cr58 Cr130 Cr
Loans & advances———0.07 Cr0.08 Cr0 Cr
Inventories244 Cr310 Cr342 Cr421 Cr660 Cr842 Cr
Trade receivables242 Cr375 Cr515 Cr615 Cr830 Cr1,212 Cr
Cash & bank32 Cr47 Cr25 Cr148 Cr229 Cr147 Cr
Other assets275 Cr348 Cr384 Cr1,068 Cr793 Cr1,166 Cr
Total assets834 Cr1,126 Cr1,309 Cr2,345 Cr2,703 Cr3,600 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-69 Cr-35 Cr-45 Cr-37 Cr-77 Cr96 Cr
Cash from investing-31 Cr-162 Cr-49 Cr-705 Cr220 Cr-303 Cr
Cash from financing89 Cr211 Cr73 Cr863 Cr-74 Cr124 Cr
Net cash flow-11 Cr14 Cr-21 Cr121 Cr69 Cr-83 Cr
Free cash flow (OCF − Capex)-78 Cr-45 Cr-51 Cr-42 Cr-88 Cr29 Cr

Ratios

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %1.5%1.1%4.7%5.3%8.7%10.1%
ROE %-3.2%-5.3%-1.9%2.4%5.4%6.6%
Debtor days505457575967
Inventory days504538394746
Days payable202023212840
Cash conversion cycle807971757873
OCF / EBITDA %n.m.n.m.n.m.n.m.-44.8%36.2%
OCF / EBITDA % (3 years)——n.m.n.m.n.m.-3.1%
Debt / equity0.290.510.630.170.170.34
Current ratio2.191.841.643.342.461.58
Net debt / EBITDA5.089.765.441.140.411.58